Clinical Trial Update: Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Anecortave Acetate to Visudyne for wet age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Visudyne (verteporfin)
• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Alcon Research | Conditions: Macular Degeneration | Phase 3 | Status: COMPLETED